GRADE Working Group

GRADE Working Group
Name	GRADE Working Group
Formation	2000s
Type	Research methodology collaboration
Headquarters	International
Leader title	Conveners

Contents

GRADE Working Group The GRADE Working Group is an international collaboration of researchers and methodologists dedicated to improving the assessment of evidence and the development of recommendations in health care. Founded to harmonize disparate approaches used by organizations such as World Health Organization, Cochrane Collaboration, and National Institute for Health and Care Excellence, the group produces guidance used by guideline developers including American College of Physicians, European Medicines Agency, and U.S. Preventive Services Task Force. The group’s framework influences policy makers, professional societies, and academic institutions such as Harvard University, University of Oxford, and Johns Hopkins University.

History and formation

The initiative emerged in the early 2000s when experts from Cochrane Collaboration, Agency for Healthcare Research and Quality, World Health Organization, Public Health Agency of Canada, and National Institutes of Health convened with methodologists from McMaster University, University of Toronto, and University of Bern to reconcile approaches used by bodies like National Institute for Health and Care Excellence and French National Authority for Health. Key figures associated with the formation include academics linked to The BMJ, The Lancet, and JAMA, and contributors with affiliations to Oxford University Press and Wiley-Blackwell. Early meetings occurred alongside conferences such as the Cochrane Colloquium, the Evidence-Based Medicine Working Group symposia, and workshops at institutions like Institute of Medicine and Karolinska Institutet.

The group developed a transparent framework to rate the certainty of evidence and strength of recommendations, integrating inputs from randomized trials, observational studies, and diagnostic research. The system refines concepts used by reviewers in Cochrane Reviews, guideline panels at World Health Organization, and health technology assessment agencies like Canadian Agency for Drugs and Technologies in Health and National Institute for Health and Care Excellence. Criteria include risk of bias, inconsistency, indirectness, imprecision, and publication bias, building on earlier work by scholars publishing in The Lancet, BMJ Quality & Safety, and Annals of Internal Medicine. The approach guides synthesis alongside methods from CONSORT, PRISMA, STROBE, and diagnostic standards such as STARD.

Clinical guideline developers at American College of Cardiology, European Society of Cardiology, American Academy of Pediatrics, and Infectious Diseases Society of America use the framework to craft recommendations for practice in areas including cardiology, oncology, infectious diseases, and primary care. Health systems such as National Health Service (England), Veterans Health Administration, and Intermountain Healthcare have incorporated the framework into pathways, quality indicators, and clinical decision support tools. Specialty societies like American Society of Clinical Oncology, Endocrine Society, and American College of Rheumatology apply the methods when producing consensus statements and guidelines referenced in journals like JAMA, The New England Journal of Medicine, and BMJ.

Adoption spans global institutions including World Health Organization, national bodies like Health Canada and Australian Department of Health, and regional consortia such as European Medicines Agency and Pan American Health Organization. Universities including Stanford University, Yale University, and University of Sydney teach the methodology in courses and workshops. Implementation features in guideline platforms such as UpToDate, DynaMed, and national formularies overseen by agencies like Medicines and Healthcare products Regulatory Agency and Brazilian Ministry of Health. International collaborations with entities like GAVI, Global Fund, and UNICEF have used the grading approach when weighing interventions.

Critiques have arisen from stakeholders at American Medical Association, patient advocacy groups, and economists at institutions like London School of Economics about the framework’s handling of complex interventions, equity considerations, and resource-limited settings. Methodologists publishing in The BMJ and Cochrane Database of Systematic Reviews have debated subjectivity in rating downgrades and upgrades, applicability to diagnostic and prognostic research, and the challenge of incorporating patient values measured by groups such as Patient-Centered Outcomes Research Institute. Health technology assessment bodies including National Institute for Health and Care Excellence and researchers at Institute for Clinical and Economic Review have discussed integration with cost-effectiveness analyses.

The collaboration operates as a distributed network of conveners, steering committee members, and contributors affiliated with institutions such as McMaster University, University of Ottawa, University of Bern, and University of Oxford. Output includes methodological articles in journals like BMJ, The Lancet, and Annals of Internal Medicine, handbooks used by World Health Organization and training materials presented at meetings such as the Cochrane Colloquium and Society for Clinical Trials annual conference. Secondary products include evidence profiles, summary of findings tables used by guideline panels including those at American College of Physicians and European Society of Radiology, and educational modules utilized by organizations like Global Health Network.

Category:Medical research organizations